Open Content

Subscribe today for access to
Articles and Reports

By Rachel Rangel, AuD | Nov 7, 2023 | 6 min read

Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.

By G2 Intelligence Staff | Sep 22, 2023 | 1 min read

G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight

By Glenn S. Demby | Sep 21, 2023 | 2 min read

The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.

By Glenn S. Demby | Dec 12, 2022 | 3 min read

What labs need to know to maximize specimen collection fee reimbursements.

By Rachel Muenz | Dec 8, 2022 | 2 min read

After being convicted on all charges he faced, the former Theranos COO was sentenced to 12 years, 11 months on Dec. 7.

By Rachel Muenz | Dec 7, 2022 | 2 min read

Co-owners sentenced to three years each for paying millions in kickbacks for referrals to their Brooklyn-based facilities.

By Glenn S. Demby | Dec 7, 2022 | 2 min read

While civil actions, criminal actions, and exclusions are up, the increased activity isn’t yet reflected in total recoveries.

By Rachel Muenz | Dec 6, 2022 | 2 min read

A recent study led by a team at the University of Gothenburg shows that multiple biomarkers could ID the disease even in people with no symptoms.

By Glenn S. Demby | Dec 5, 2022 | 2 min read

Learn why this is the perfect time of the year to mobilize your board members.

By Rachel Muenz | Nov 30, 2022 | 2 min read

Readers can now gain full access to our four briefings for up to seven days for free.

By Glenn S. Demby | Nov 30, 2022 | 2 min read

The company’s third attempt at shaking up the healthcare industry, Amazon Clinic, might just prove the charm.

By Rachel Muenz | Nov 30, 2022 | 2 min read

Enforcement actions over our most recent coverage period were related to other areas of the healthcare industry.

By Glenn S. Demby | Nov 28, 2022 | 2 min read

M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.